Professor Ric Price

Professor of global health; senior principal research fellow; staff specialist in infectious diseases and general medicine, Division of Medicine, Royal Darwin Hospital

Qualifications:

Bachelor of Arts, University of Cambridge, 1983; Bachelor of Medicine and Bachelor of Surgery, University of Cambridge, 1989; Master of Arts, University of Cambridge, 1990; Medical Doctorate, University of London, 2000; Fellow of The Royal Australian College of Physicians, 2004; Fellow of The Royal College of Physicians, UK, 2005; Fellow of The Royal College of Pathologists, UK, 2008; Fellow of the Academy of Medical Science, UK, 2019; ASTMH Distinguished International Fellow, USA, 2020

Approved level of HDR supervision at Charles Darwin University:

Principal Supervisor for PhD

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Professor Ric Price is an infectious disease and general physician on the staff at the Royal Darwin Hospital. He holds a dual academic affiliation as professor of global health at the Menzies School of Health Research and professor of tropical medicine at the Centre of Tropical Medicine, University of Oxford, UK.

He is an expert in malaria therapeutics, antimalarial drug resistance and P. vivax epidemiology with a translational research agenda that spans clinical drug trials, epidemiology, parasitology, molecular biology, social science and health economics.

The ultimate aim of Ric’s research is to change public health policy and impact upon global health outcomes. To achieve this he is coordinating a program involving collaborators from 32 countries, working with local partners to provide the evidence needed to optimise policy and practice, building in-country research capacity and strengthening national malaria surveillance systems to support the global elimination of malaria.

Professor Price chairs the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and between 2010-2020, co-chaired the Vivax Working Group of the Asia-Pacific Malaria Elimination Network (APMEN).

In 2021, Ric was elected as a Fellow of the Australian Academy of Health and Medical Sciences. 

  1. Devine, A., Battle, K. E., Meagher, N., Howes, R. E., Dini, S., Gething, P. W., Simpson, J. A., Price, R. N., & Lubell, Y. (2021). Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLoS medicine, 18(6), e1003614. https://doi.org/10.1371/journal.pmed.1003614
  2. Pfeffer, D. A., Ley, B., Howes, R. E., Adu, P., Alam, M. S., Bansil, P., Boum, Y., Brito, M., Charoenkwan, P., Clements, A., Cui, L., Deng, Z., Egesie, O. J., Espino, F. E., von Fricken, M. E., Hamid, M., He, Y., Henriques, G., Khan, W. A., Khim, N.…Price, R. N. (2020). Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis. PLoS medicine, 17(5), e1003084. https://doi.org/10.1371/journal.pmed.1003084
  3. Taylor, W., Thriemer, K., von Seidlein, L., Yuentrakul, P., Assawariyathipat, T., Assefa, A….Price, R. N. (2019). Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. The Lancet, 394(10202), 929-938. https://doi.org/10.1016/s0140-6736(19)31285-1
  4. Hossain, M. S., Commons, R. J., Douglas, N. M., Thriemer, K., Alemayehu, B. H., Amaratunga, C., Anvikar, A. R., Ashley, E. A., Asih, P., Carrara, V. I., Lon, C., D'Alessandro, U., Davis, T., Dondorp, A. M., Edstein, M. D., Fairhurst, R. M., Ferreira, M. U., Hwang, J., Janssens, B., Karunajeewa, H.…Price, R. N. (2020). The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS medicine, 17(11), e1003393. https://doi.org/10.1371/journal.pmed.1003393
  5. Commons, R. J., Simpson, J. A., Thriemer, K., Humphreys, G. S., Abreha, T., Alemu, S. G., Añez, A., Anstey, N. M., Awab, G. R., Baird, J. K., Barber, B. E., Borghini-Fuhrer, I., Chu, C. S., D'Alessandro, U., Dahal, P., Daher, A., de Vries, P. J., Erhart, A., Gomes, M., Gonzalez-Ceron, L.…Price, R. N. (2018). The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. The Lancet. Infectious diseases, 18(9), 1025–1034. https://doi.org/10.1016/S1473-3099(18)30348-7
  6. Auburn, S., Benavente, E., Miotto, O., Pearson, R., Amato, R., Grigg, M….Price, R. N. (2018). Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-04965-4
  7. Douglas, N. M., Poespoprodjo, J. R., Patriani, D., Malloy, M. J., Kenangalem, E., Sugiarto, P., Simpson, J. A., Soenarto, Y., Anstey, N. M., & Price, R. N. (2017). Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study. PLoS medicine, 14(8), e1002379. https://doi.org/10.1371/journal.pmed.1002379
  8. Abreha, T., Hwang, J., Thriemer, K., Tadesse, Y., Girma, S., Melaku, Z….Price, R. N. (2017). Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLOS Medicine, 14(5), e1002299. https://doi.org/10.1371/journal.pmed.1002299
  9. Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014). Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet. Infectious diseases, 14(10), 982–991. https://doi.org/10.1016/S1473-3099(14)70855-2
  10. Ratcliff, A., Siswantoro, H., Kenangalem, E., Maristela, R., Wuwung, R. M., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E., & Price, R. N. (2007). Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet (London, England), 369(9563), 757–765. https://doi.org/10.1016/S0140-6736(07)60160-3
  11. Price, R. N., Uhlemann, A. C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., Nosten, F., & Krishna, S. (2004). Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet (London, England), 364(9432), 438–447. https://doi.org/10.1016/S0140-6736(04)16767-6
  12. Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Chongsuphajaisiddhi, T., & White, N. J. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet (London, England), 347(9016), 1654–1658. https://doi.org/10.1016/s0140-6736(96)91488-9
Click here to view more Ric Price publications in PubMed.
  1. MEDIA RELEASE | Menzies researchers RESPOND to priority diseases in our global neighbourhood

    MEDIA RELEASE | Menzies researchers RESPOND to priority diseases in our global neighbourhood

    Date

    Menzies will lead a 4-year health system strengthening partnership in the Asia-Pacific region, under the Partnerships for a Healthy Region Initiative by the Australian Government.

  2. MEDIA RELEASE | Menzies researchers in the top 2 per cent

    MEDIA RELEASE | Menzies researchers in the top 2 per cent

    Date

    Menzies School of Health Research is celebrating the work of its researchers who have been ranked amongst the world’s top scientists.

  3. The history of Malaria and its global elimination by Professor Ric Price

    The history of Malaria and its global elimination by Professor Ric Price

    Date

    The first in a series of public lectures hosted by CDU-Menzies School of Medicine kicked off on 17 March with Menzies Professor of Global Health Professor Ric Price giving a talk on the history of Malaria and its global elimination.

  4. Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

    Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

    Date

    A new malaria study using a very large analysis of pooled individual patient data from more than 70,000 patients of all ages, has been published in BMC Medicine. Picture credit: Flickr, Cristhian Alama, Red Mundial

  5. Public lectures share expert insights in health

    Public lectures share expert insights in health

    Date

    The series will kick off with a lecture on March 17 with the Professor of Global Health at Menzies School of Health Research (Menzies), Professor Ric Price, who will talk about the history of Malaria and its global elimination.

  6. Researchers at CDU some of the most influential in their fields

    Researchers at CDU some of the most influential in their fields

    Date

    According to a Stanford University study, there were 22 academics from CDU and Menzies School of Health research who ranked in the top two per cent of researchers referenced in their respected disciplines for 2020.

  7. NT News | Territory shares in funding

    NT News | Territory shares in funding

    Date

    MENZIES School of Health Research professor Richard Price will spearhead research to eliminate malaria, thanks to a $2.9m grant through the federal government’s National Health and Medical Research Council (NHMRC) investigator grant scheme.

  8. New insights into immune responses to malaria

    New insights into immune responses to malaria

    Date

    Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.

  9. New Partnership to Help Eliminate Complex and Persistent Malaria

    New Partnership to Help Eliminate Complex and Persistent Malaria

    Date

    The Indonesia Ministry of Health, Universitas Gadjah Mada, University of Indonesia, Universitas Sumatera Utara, and Menzies are embarking upon a new program to improve the management of patients with Plasmodium vivax malaria.

  10. New Partnership launched to accelerate elimination of relapsing P. vivax malaria

    New Partnership launched to accelerate elimination of relapsing P. vivax malaria

    Date

    As part of PAVE, Medicines for Malaria Venture (MMV), PATH, Menzies School of Health Research, and Burnet Institute will work with in-country partners to conduct feasibility studies looking at the best way to use different P. vivax relapse treatments and diagnostics at different levels of the healthcare system in endemic countries.

  11. A New $25 Million Unitaid Partnership to Help Eliminate Complex and Persistent Malaria

    A New $25 Million Unitaid Partnership to Help Eliminate Complex and Persistent Malaria

    Date

    Brazil, Ethiopia, India, Indonesia, Papua New Guinea, Peru and Thailand are set to benefit from a $25-million “Partnership for Vivax Elimination” (PAVE) which aims to help these countries eliminate Plasmodium vivax (P. Vivax) malaria.

  12. First study to estimate the global costs due to vivax malaria

    First study to estimate the global costs due to vivax malaria

    Date

    The global cost of vivax malaria infections could be reduced substantially if radical cure is used more effectively, a new paper has found.

  13. MEDIA RELEASE | First study to estimate the global costs due to vivax malaria

    MEDIA RELEASE | First study to estimate the global costs due to vivax malaria

    Date

    The global cost of vivax malaria infections could be reduced substantially if radical cure is used more effectively, a new paper has found.

  14. Hidden malaria life cycle discovered in the spleen

    Hidden malaria life cycle discovered in the spleen

    Date

    Ground-breaking studies published today in the New England Journal of Medicine and PLOS Medicine have found large numbers of malaria parasites hiding in the human spleen where they actively multiply in a previously unrecognised life cycle.

  15. Finding innovative solutions to eliminate vivax malaria by 2030

    Finding innovative solutions to eliminate vivax malaria by 2030

    Date

    New research by Menzies’ malaria team is identifying innovative new ways to eliminate Plasmodium vivax (P. vivax) malaria by 2030.

  16. CDU academics named among world’s most influential

    CDU academics named among world’s most influential

    Date

    Menzies School of Health Research Professor Bart Currie, Professor Anne Chang AM, Professor Ric Price, Associate Professor Steven Tong, Professor Nicholas Anstey, Professor Joshua Davis, Professor Alan Cass, Professor Peter Morris and Professor Amanda Leach

  17. An open letter from 119 scientists and researchers to The Lancet

    An open letter from 119 scientists and researchers to The Lancet

    Date

    Signed by clinicians, medical researchers, statisticians, and ethicists from across the world, follows the publication of a paper on using hydroxychloroquine or chloroquine for the treatment of COVID-19.

  18. Calls for a universal radical cure to treat malaria

    Calls for a universal radical cure to treat malaria

    Date

    The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.

  19. Calls for a universal radical cure to treat malaria

    Calls for a universal radical cure to treat malaria

    Date

    The elimination of malaria from the Asia Pacific within the decade will require the safe and effective radical cure of malaria, a new paper in Trends in Parasitology suggests.

  20. Trump’s Faulty Malaria-Coronavirus Connection

    Trump’s Faulty Malaria-Coronavirus Connection

    Date

    President Trump has suggested there are few novel coronavirus cases in “malaria countries” because of the use of the antimalarial drug hydroxychloroquine.

  21. Menzies investigators and international collaborators from ACROSS and other institutions have published a meta-analysis

    Menzies investigators and international collaborators from ACROSS and other institutions have published a meta-analysis

    Date

    Menzies investigators and international collaborators have published a meta-analysis and identified a point of care test for the diagnosis of G6PD deficiency with suitable reliability for routine use. Further feasibility studies are under way to assess its reliability under field conditions.

  22. Media Release | Malaria researcher awarded national fellowship

    Media Release | Malaria researcher awarded national fellowship

    Date

    Menzies School of Health (Menzies) researcher Dr Kamala Thriemer has been awarded a prestigious $1.25 million CSL Centenary Fellowship to develop and optimise treatment programs against vivax malaria in SE Asia and the Horn of Africa.

  23. New Research Pinpoints Faster Treatment to Cure Vivax Malaria

    New Research Pinpoints Faster Treatment to Cure Vivax Malaria

    Date

    A new research study has shown that a seven-day treatment with a high dose of an anti-malaria drug can be tolerated by patients

  24. New study shows faster way to cure vivax malaria

    New study shows faster way to cure vivax malaria

    Date

    A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated.

  25. 7th International Conference on Plasmodium vivax Research | Final Report

    7th International Conference on Plasmodium vivax Research | Final Report

    Date

    MESA Correspondents bring you cutting-edge coverage from the 7th International Conference on Plasmodium vivax Research (ICPVR 2019).

  26. Coverage from the 7th International Conference on Plasmodium vivax Research

    Coverage from the 7th International Conference on Plasmodium vivax Research

    Date

    Wrapping up the 7th International Conference on Plasmodium vivax Research, day three focused on the topics of P. vivax drugs and approaches for P. vivax elimination.

  27. 50 Top Biomedical And Health Scientists Join Prestigious Academy Of Medical Sciences Fellowship

    50 Top Biomedical And Health Scientists Join Prestigious Academy Of Medical Sciences Fellowship

    Date

    Prof Ric Price recognised by The Academy of Medical Sciences as one of 50 of the UK’s leading figures elected to their esteemed Fellowship.

  28. 50 top biomedical and health scientists join prestigious Academy of Medical Sciences Fellowship

    50 top biomedical and health scientists join prestigious Academy of Medical Sciences Fellowship

    Date

    Professor Richard Price , Professor of Global Health and Senior Principal Research Fellow, Menzies School of Health Research, and Professor of Tropical Medicine, University of Oxford

  29. Asia–Pacific research partnerships set to tackle big challenges

    Asia–Pacific research partnerships set to tackle big challenges

    Date

    The largest grant, of $257,767, goes to the Menzies School of Health Research for a project with collaborators in Bangladesh, Indonesia and the Netherlands.

  30. SMH | Commonwealth regional research grants key to 'science diplomacy'

    SMH | Commonwealth regional research grants key to 'science diplomacy'

    Date

    Among the other projects funded are the Menzies School of Health Research partnering with Bangladesh, Indonesia and Nepal to develop malaria treatments.

  31. ScienceNews | A newly approved drug could be a boon for treating malaria

    ScienceNews | A newly approved drug could be a boon for treating malaria

    Date

    The first new treatment in 60 years for a particularly stubborn kind of malaria is raising hopes that it might help eradicate the disease.

  32. Improving P. vivax malaria treatment

    Improving P. vivax malaria treatment

    Date

    A study, led by a team at Menzies School of Health Research in Australia, has assembled individual patient data from clinical trials conducted since 2000, investigating the effect of chloroquine dosing, combined with the partner drug primaquine, and the risk of recurrent malaria across different settings.

  33. NT News | Malaria breakthrough for NT

    NT News | Malaria breakthrough for NT

    Date

    NT News page 7 - 21 July 2018 | Report on The Lancet Infectious Diseases P.vivax paper.

  34. Xinhua News | "Radical cure" best treatment for common malaria: study

    Xinhua News | "Radical cure" best treatment for common malaria: study

    Date

    (Xinhua) -- Researchers have discovered that a "radical cure" is the best treatment for a type of malaria affecting 13 million people.

  35. New evidence supports radical treatment of  widespread form of malaria

    New evidence supports radical treatment of widespread form of malaria

    Date

    A team of malaria experts from a large international research collaboration has today published results supporting the need for a radical cure strategy to tackle one of the most debilitating forms of malaria caused by the Plasmodium vivax parasite.

  36. Australian support for eliminating malaria and health research in the Indo-Pacific

    Australian support for eliminating malaria and health research in the Indo-Pacific

    Date

    Australia is playing a leading role in supporting malaria elimination efforts, particularly in the Indo-Pacific. The Government's Stronger Systems for Health Security program is supporting practical, relevant research into fundamental health security challenges.

  37. Malaria victim facing double hand amputation considers legal action against GP

    Malaria victim facing double hand amputation considers legal action against GP

    Date

    Malaria expert Professor Ric Price, from the Menzies School of Health Research in Darwin, said advising travellers about the prevention of malaria was not straightforward.

  38. NT News | Brains Trust Born

    NT News | Brains Trust Born

    Date

    Researchers at Darwin's Menzies School of Health Research will play a key role in a new push to fight the scourge of malaria in the Asia-Pacific region.

  39. New Australian-led malaria research powerhouse gears up to hunt down malaria across the Asia-Pacific

    New Australian-led malaria research powerhouse gears up to hunt down malaria across the Asia-Pacific

    Date

    Australia will take a leadership role in the Asia-Pacific region in a new initiative to help our nearest neighbours rid the scourge of malaria, in a new National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Malaria Elimination.

  40. Curious Darwin: Why is there no malaria in Australia's northern capital?

    Curious Darwin: Why is there no malaria in Australia's northern capital?

    Date

    Professor Ric Price is an expert in malaria who works at the Menzies School of Health Research in Darwin. He said the victory over malaria was a result of prompt and effective diagnosis, actions to control mosquito numbers, and close follow-up of people who returned home from overseas who were sick with malaria.

  41. Scientists complete the genome sequences of malaria parasites

    Scientists complete the genome sequences of malaria parasites

    Date

    An international team of scientists has sequenced the genomes of the final two species of malaria parasites. The findings have important implications for malaria eradication worldwide and will help researchers to develop new drugs and a vaccine.

  42. $2m grant to combat drug resistant malaria and tuberculosis

    $2m grant to combat drug resistant malaria and tuberculosis

    Date

    A $2m research grant to work towards the prevention, control and elimination of malaria and tuberculosis (TB) in Southeast Asia and the Pacific has been awarded to a consortium led by Menzies School of Health Research, in collaboration with Burnet Institute, the Department of Foreign Affairs and Trade announced today.

  43. Burnet Institute Director's Seminar | Part two

    Burnet Institute Director's Seminar | Part two

    Date

    Click here to view on YouTube

  44. Burnet Institute Director's Seminar | Part one

    Burnet Institute Director's Seminar | Part one

    Date

    Click to view on YouTube

  45. TerritoryQ: War on Malaria, Prof Ric Price and Prof Nicholas Anstey

    TerritoryQ: War on Malaria, Prof Ric Price and Prof Nicholas Anstey

    Date

    A medical team based in Darwin has put itself at the centre of the goal to eliminate malaria from the Asia-Pacific

  46. Research reveals extent of drug resistant vivax malaria

    Research reveals extent of drug resistant vivax malaria

    Date

    New research into the extent and nature of drug resistant malaria is hoping to benefit the millions of people worldwide who suffer from the potential deadly disease.

  47. Menzies contributes to key antimalarial recommendations from multinational network

    Menzies contributes to key antimalarial recommendations from multinational network

    Date

    A new study by a global collaborative platform for scientists and clinical researchers hopes to address antimalarial drug resistance which continues to hamper malaria control programs.

  48. ABC AM: New research into fighting malaria

    ABC AM: New research into fighting malaria

    Date

    Scientists say new research into malaria will help provide new ways to combat the deadly disease.

  49. Radio Australia: Hopes that genetic mapping will outwit malaria parasite

    Radio Australia: Hopes that genetic mapping will outwit malaria parasite

    Date

    Scientists say new research into the malaria parasite will provide drugs to combat the ways it's evolving to gain resistance to the current range of anti-malaria medicine.

  50. Aljazeera News: Call for global action to tackle Malaria

    Aljazeera News: Call for global action to tackle Malaria

    Date

    Countries around the world need to do more to fight the spread of malaria, according to a new report by the World Health Organisation (WHO).